Lilly to cut some list prices by 70% and offer $25 insulin
on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the fourth quarter of this year, a move that could help millions of Americans afford their medicine. The Indianapolis-based drugmaker also will lower the price of…#elilillyandco #humulin #indianapolis #lispro #medicare #davericks #elililly #novonordisk #lilly #sanofi (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2023 Category: Consumer Health News Source Type: news

Eli Lilly finally gives into insulin price-cut pressure
Some diabetic Americans will finally be able to spend less than their monthly internet bill to pick up life-saving medicine. Drugmaker Eli Lilly said yesterday it would slash the list prices for its two most prescribed insulin products, Humalog and Humulin, by 70%. It also said it would cap…#drugmakerelililly #humulin #elililly #lilly #medicare #bidenandco #seanmorrow #sanofi #novonordisk (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2023 Category: Consumer Health News Source Type: news

Drugs giant Eli Lilly caps monthly insulin costs in US at $35
Eli Lilly said it would institute the cap on out-of-pocket costs for Lilly insulin users immediately as it prepares to cut the list price of two of its most commonly prescribed insulins, Humalog and Humalin, by 70% by the end of the year. "While the current healthcare system provides access to…#elililly #lilly #davidaricks #lillychair #medicare #ravilulla #omaha #nebraska #mrricksoflilly (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2023 Category: Consumer Health News Source Type: news

Lilly to cut price of insulin for people with commercial health insurance
Eli Lilly & Co. LLY said Wednesday that is capping out-of-pocket insulin costs to $35 for people with commercial health insurance at certain retail pharmacies and it is also lowering the prices of most its insulins, such as pricing non-branded Insulin Lispro at $25 a vial. The company also plans…#elilillyco #lly #insulinlispro #humalogandhumulin #lilly #lantus (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2023 Category: Consumer Health News Source Type: news

Eli Lilly Plans To Slash Some Insulin Prices and Expand Cost Cap
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live. Lilly’s changes also come as lawmakers and patient advocates pressure drugmakers to do something about soaring prices. Lilly said it will cut the list price for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% in the fourth quarter, which starts in September. The drug...
Source: TIME: Health - March 1, 2023 Category: Consumer Health News Authors: Tom Murphy/AP Tags: Uncategorized Drugs healthscienceclimate wire Source Type: news

NLM Technical Bulletin, Jan-Feb 2023, RxNorm January 2023 Monthly Release
The RxNorm January 2023 monthly release became available on Tuesday, January 3, 2022 and includes a separate RxNorm Concept Unique Identifier (RXCUI) of 2621572 for the Humalog Tempo Pen insulin product with sensor. (Source: NLM Technical Bulletin)
Source: NLM Technical Bulletin - January 3, 2023 Category: Databases & Libraries Source Type: news

Lyumjev OK'd for Kids; Sand for Weight Loss? AGA's New Obesity Guidelines
(MedPage Today) -- The FDA expanded the indication for rapid-acting mealtime insulin lispro-aabc (Lyumjev) to now also include children ages 1 year and older with diabetes, based on the phase III PRONTO-Peds trial, Eli Lilly announced. Estimating... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 25, 2022 Category: Endocrinology Source Type: news

Lyumjev (insulin lispro-aabc) Injection Approved by U.S. FDA for Children with Diabetes
October 14, 2022 -- The U.S. Food and Drug Administration (FDA) approved an expansion of the indication for Eli Lilly and Company ' s rapid-acting mealtime insulin Lyumjev® (insulin lispro-aabc) injection to include the improvement of glycemic... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 14, 2022 Category: Drugs & Pharmacology Source Type: news

Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India
This will allow Cipla to expand access to the drugs in the country with the second-highest number of diabetic people in the world. India has more than 70 million adults with diabetes. (Source: The Economic Times)
Source: The Economic Times - October 4, 2021 Category: Consumer Health News Source Type: news

Lyumjev (Insulin Lispro-aabc Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 27, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Lyumjev (insulin lispro-aabc injection) 100 units/mL for Use in Insulin Pumps
INDIANAPOLIS, Aug. 16, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved an expanded label for Eli Lilly and Company ' s (NYSE: LLY) rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) 100 units/mL indicated to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 16, 2021 Category: Drugs & Pharmacology Source Type: news

Walmart Announces Its Own Brand of Low-Cost Analog Insulin
Walmart Inc. will offer its own brand of analog insulin for people with diabetes, an effort to boost its pharmacy business and counter Amazon.com Inc.’s recent push to sell more medications. The world’s largest retailer will begin selling ReliOn NovoLog this week in its U.S. pharmacies with a prescription, Walmart said in a statement Tuesday. The medicine will cost between 58% and 75% less than the current cash price of branded insulin products for uninsured patients, Walmart said. More than 3 million Walmart customers are diabetic, and the retailer already offers human insulin to them for about $25. But that t...
Source: TIME: Health - June 29, 2021 Category: Consumer Health News Authors: Matthew Boyle and Angelica LaVito / Bloomberg Tags: Uncategorized Companies wire Source Type: news

Lyumjev (Insulin Lispro-aabc Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 22, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Lilly's Ultra-Rapid-Acting Insulin, Lyumjev FDA Approves Lilly's Ultra-Rapid-Acting Insulin, Lyumjev
The novel rapid-acting formulation of insulin lispro is approved for adults with type 1 and type 2 diabetes.FDA Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 18, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA Approves Lyumjev (insulin lispro-aabc injection) for Type 1 and Type 2 Diabetes
INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company ' s (NYSE: LLY) new rapid-acting insulin indicated to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 15, 2020 Category: Drugs & Pharmacology Source Type: news